Consonance Capital Management LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2017. The put-call ratio across all filers is 11.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2017$66,912,000
-3.9%
2,079,311
+3.8%
6.04%
-21.6%
Q3 2017$69,648,000
+16.2%
2,002,519
-0.5%
7.70%
+9.1%
Q2 2017$59,913,000
+41.3%
2,012,519
+41.7%
7.06%
+58.8%
Q1 2017$42,409,0001,420,7424.44%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2017
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders